Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.29118 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.26524 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.2535 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.21053 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.20829 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.36011 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.33971 | 13 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.24447 | 11 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.23251 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25257 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.25263 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23886 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.26655 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.25391 | 11 |